Search results

Order by most recent / most popular / relevance

Results: 1-10 of 235

Reconditioning consumer products

Matheson
-
United Kingdom
-
May 16 2013

In Schütz v Werit (2013 UKSC 16), the UK Supreme Court issued a decision which will be of significance to the providers of replacement parts

IP challenges for the personalised medicines industry - gene claims (part 1)

Barker Brettell LLP
-
European Union, United Kingdom, USA
-
May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

To use or not to use?

Taylor Wessing LLP
-
United Kingdom
-
April 29 2013

Confidentiality agreements have widespread application and are of course entered into extremely regularly in many different contexts, both in

U.K. jumps on “pay-to-delay” bandwagon

Fish & Richardson PC
-
United Kingdom, USA
-
April 24 2013

The U.K. Office of Fair Trading ("OFT") jumped on the "pay-to-delay" bandwagon last week when it issued a "Statement of Objections," indicating a

It takes two to tangoUK High Court considers patent for anti-malarial combination product obvious

A.A. Thornton & Co.
-
United Kingdom
-
April 24 2013

The UK High Court has recently handed down a further decision relating to the validity of pharmaceutical combination patents. In the decision

Omnipharm v Merial winner gets it spot-on

EIP
-
United Kingdom
-
April 23 2013

In Omnipharm Limited v Merial 2013 EWCA Civ 2, the Court of Appeal of England and Wales (CA) upheld a first instance decision to revoke one of

When is making a patented product not an infringement? Werit is making a repair

Carpmaels & Ransford
-
United Kingdom
-
April 17 2013

The recent judgment in Schütz v Werit from the Supreme Court (the United Kingdom's highest court) has provided guidance on the question of when

Supreme Court holds that replacement product part was not a violation of patent

Latham & Watkins LLP
-
United Kingdom
-
April 15 2013

Supreme Court provides the secondary market with valuable guidance as to when the repair of a patented product will amount to an infringing

Angiogenesis patent found to be valid by the Court of Appeal of England and Wales

McDermott Will & Emery
-
United Kingdom
-
April 15 2013

In Regeneron Pharmaceuticals Inc. and Bayer Pharma AG v Genentech Inc 2013 EWCA Civ 93 the Court of Appeal of England and Wales found that a patent

UK Supreme Court provides guidance on “making” a product

McDermott Will & Emery
-
United Kingdom
-
April 15 2013

In Schütz (UK) Limited v Werit (UK) Limited 2013 UKSC 16 the UK Supreme Court has provided guidance on the meaning of “making” a product, as

next >

Search results

Reconditioning consumer products

IP challenges for the personalised medicines industry - gene claims (part 1)

To use or not to use?

U.K. jumps on “pay-to-delay” bandwagon

It takes two to tangoUK High Court considers patent for anti-malarial combination product obvious

Omnipharm v Merial winner gets it spot-on

When is making a patented product not an infringement? Werit is making a repair

Supreme Court holds that replacement product part was not a violation of patent

Angiogenesis patent found to be valid by the Court of Appeal of England and Wales

UK Supreme Court provides guidance on “making” a product

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea